The Role of Alpha-lipoic Acid Supplementation in the Prevention of Diabetes Complications: A Comprehensive Review of Clinical Trials

(E-pub Ahead of Print)

Author(s): Sarah Jeffrey, Punitha Isaac Samraj*, Behin Sundara Raj

Journal Name: Current Diabetes Reviews


Article ID: e011821190404
Become EABM
Become Reviewer
Call for Editor

Abstract:

Alpha-lipoic acid (ALA) is a substantial antioxidant in the prevention of diabetes and diabetes complications. It can regenerate other antioxidants like vitamin E, vitamin C, Coenzyme Q10 and glutathione and is often known as a universal antioxidant. Antioxidants play a role in diabetes treatment due to hyperglycemia-induced stimulation of the polyol pathway and formation of advanced glycation end products (AGE) and reactive oxygen species (ROS). Clinical trials examining alpha-lipoic acid supplementation on diabetic neuropathy, nephropathy, cardiomyopathy and erectile dysfunction display positive results, particularly in pain amelioration in neuropathy, asymmetric dimethylarginine reductions in nephropathy and improved oscillatory potential and contrast sensitivity in retinopathy. In diabetic cardiomyopathy (DCM), ALA offers protection through inhibition of NF-kB activation, reduction of fas-ligand and decrease in matrix metalloproteinase-2. This comprehensive review summarises and provides an understanding of the importance of alpha-lipoic acid supplementation to prevent diabetes complications.

Keywords: Alpha-lipoic acid, Diabetes mellitus, Diabetic neuropathy, Cardiomyopathy, Diabetic nephropathy

Rights & PermissionsPrintExport Cite as

Article Details

Article ID: e011821190404
Published on: 18 January, 2021
(E-pub Ahead of Print)
DOI: 10.2174/1573399817666210118145550
Price: $95

Article Metrics

PDF: 228